Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAA50 | Q9GZZ1 | 2/20 | 0.84 |
| ▸ | CHAT | P28329 | 2/20 | 0.81 |
| ▸ | EP300 | Q09472 | 3/20 | 0.79 |
| ▸ | KAT5 | Q92993 | 2/20 | 0.79 |
| ▸ | AURKA | O14965 | 2/20 | 0.79 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.79 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20857028 | 1.00 | NAA50 (0.84) | NAA50CHATEP300KAT5AURKA | |
| Succinic Acid SCHEMBL29359560 | 1.00 | NAA50 (0.84) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL285428 | 0.97 | NAA50 (0.84) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL19181359 | 0.97 | NAA50 (0.83) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL420710 | 0.96 | NAA50 (0.85) | NAA50CHATEP300KAT5AURKA | |
| Succinyl-Coa SCHEMBL4360979 | 0.96 | NAA50 (0.87) | NAA50CHATEP300KAT5AURKA | |
| Succinyl-Coa SCHEMBL31385487 | 0.96 | NAA50 (0.87) | NAA50CHATEP300KAT5AURKA | |
| Succinyl-Coa SCHEMBL4364428 | 0.96 | NAA50 (0.87) | NAA50CHATEP300KAT5AURKA | |
| Succinyl-Coa SCHEMBL4360968 | 0.96 | NAA50 (0.87) | NAA50CHATEP300KAT5AURKA | |
| Succinyl-Coa SCHEMBL50744 | 0.96 | NAA50 (0.87) | NAA50CHATEP300KAT5AURKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 499 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12577591-B2 | Microorganisms and methods for increasing co-factors | GENOMATICA, INC. (US) | 2026-03-17 | — | — | US | claimed |
| US-12577592-B2 | Genetically modified microorganism for producing 3-hydroxyhexanedioic acid and/or (e)-hex-2-enedioic acid and production method for said chemicals | TORAY INDUSTRIES, INC. (JP) | 2026-03-17 | — | — | US | claimed |
| US-20260028651-A1 | METHOD OF PRODUCING & PROCESSING DIAMINES | AGAIN BIO APS (DK) | 2026-01-29 | — | — | US | claimed |
| US-20250382643-A1 | GENETICALLY MODIFIED MICROORGANISM FOR PRODUCING 3-HYDROXYADIPIC ACID AND/OR Alpha-HYDROXYADIPIC ACID, AND METHOD FOR PRODUCING CHEMICAL PRODUCT | TORAY INDUSTRIES, INC. (JP) | 2025-12-18 | — | — | US | claimed |
| US-20250215461-A1 | GENETICALLY MODIFIED MICROORGANISM FOR PRODUCING 3-HYDROXYADIPIC ACID AND/OR 3-OXOADIPIC ACID, AND PRODUCTION METHOD FOR SAID CHEMICAL PRODUCTS | TORAY INDUSTRIES, INC. (JP) | 2025-07-03 | — | — | US | claimed |
| US-12275979-B2 | Gene-modified microorganism for producing 3-hydroxyadipic acid, alpha-hydromuconic acid, and/or adipic acid, and production method for said chemical products | TORAY INDUSTRIES, INC. (JP) | 2025-04-15 | — | — | US | claimed |
| WO-2025063258-A1 | GENE-MODIFIED MICROORGANISM FOR PRODUCING α-HYDROMUCONIC ACID AND/OR ADIPIC ACID AND METHOD FOR PRODUCING SAID CHEMICAL PRODUCT | 東レ株式会社 | 2025-03-27 | — | — | WO | claimed |
| EP-4497819-A1 | GENETICALLY-MODIFIED MICROORGANISM FOR PRODUCING 3-HYDROXYADIPIC ACID AND/OR 3-OXOADIPIC ACID AND PRODUCTION METHOD FOR SAID CHEMICAL PRODUCTS | Toray Industries, Inc. (JP) | 2025-01-29 | — | — | EP | claimed |
| EP-4481050-A1 | GENETICALLY MODIFIED MICROORGANISM FOR PRODUCING 3-HYDROXYADIPIC ACID AND/OR ALPHA-HYDROMUCONIC ACID, AND METHOD FOR PRODUCING CHEMICAL PRODUCT | Toray Industries, Inc. (JP) | 2024-12-25 | — | — | EP | claimed |
| WO-2024242124-A1 | GENETICALLY MODIFIED MICROORGANISM FOR PRODUCING 3-HYDROXYADIPIC ACID, α-HYDROMUCONIC ACID, AND/OR ADIPIC ACID, AND METHOD FOR PRODUCING SAID CHEMICALS | 東レ株式会社 | 2024-11-28 | — | — | WO | claimed |
| EP-3362567-A1 | GENETICALLY ENGINEERED BACTERIUM COMPRISING ENERGY-GENERATING FERMENTATION PATHWAY | Lanzatech New Zealand Limited (NZ) | 2018-08-22 | — | — | EP | claimed |
| EP-3351619-A1 | MICROORGANISMS FOR THE PRODUCTION OF ADIPIC ACID AND OTHER COMPOUNDS | Genomatica, Inc. (US) | 2018-07-25 | — | — | EP | claimed |
| EP-3237629-A1 | METHOD OF PRODUCING&PROCESSING DIAMINES | Genomatica, Inc. (US) | 2017-11-01 | — | — | EP | claimed |
| WO-2017066498-A1 | GENETICALLY ENGINEERED BACTERIUM COMPRISING ENERGY-GENERATING FERMENTATION PATHWAY | LANZATECH NEW ZEALAND LIMITED (NZ) | 2017-04-20 | — | — | WO | claimed |
| US-9458480-B2 | Microorganisms and methods for the biosynthesis of adipate, hexamethylenediamine and 6-aminocaproic acid | GENOMATICA, INC. (US) | 2016-10-04 | — | — | US | claimed |
| WO-2016106367-A1 | METHOD OF PRODUCING & PROCESSING DIAMINES | GENOMATICA, INC. (US) | 2016-06-30 | — | — | WO | claimed |
| US-20140178949-A1 | ADIPATE (ESTER OR THIOESTER) SYNTHESIS | DSM IP ASSETS B.V. (NL) | 2014-06-26 | — | — | US | claimed |
| US-20130303723-A1 | MICROORGANISMS AND METHODS FOR THE BIOSYNTHESIS OF ADIPATE, HEXAMETHYLENEDIAMINE AND 6-AMINOCAPROIC ACID | AGAIN BIO APS (DK) | 2013-11-14 | — | — | US | claimed |
| US-8062871-B2 | Microorganisms for the production of adipic acid and other compounds | GENOMATICA, INC. (US) | 2011-11-22 | — | — | US | claimed |
| US-20110195466-A1 | MICROORGANISMS FOR THE PRODUCTION OF ADIPIC ACID AND OTHER COMPOUNDS | GENOMATICA, INC. (US) | 2011-08-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250215461-A1 | GENETICALLY MODIFIED MICROORGANISM FOR PRODUCING 3-HYDROXYADIPIC ACID AND/OR 3-OXOADIPIC ACID, AND PRODUCTION METHOD FOR SAID CHEMICAL PRODUCTS | HMGCR, GNPAT, COASY | NAA50 1306/4885CHAT 1679/4885EP300 2519/4885 |
| US-20260028651-A1 | METHOD OF PRODUCING & PROCESSING DIAMINES | DDC, DAO, ODC1 | NAA50 69/4885CHAT 77/4885EP300 1948/4885 |
| US-12577591-B2 | Microorganisms and methods for increasing co-factors | ABAT, HADHB, MMAB | NAA50 278/4885CHAT 1499/4885EP300 3766/4885 |
| US-12577592-B2 | Genetically modified microorganism for producing 3-hydroxyhexanedioic acid and/or (e)-hex-2-enedioic acid and production method for said chemicals | HACL2, HPD, ACADM | NAA50 1810/4885CHAT 3661/4885EP300 4094/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.